Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997

Autor: Aaron S. Kesselheim, Reed F. Beall, Aidan Hollis, Babak Sahragardjoonegani

Publikováno v: Journal of Pharmaceutical Policy and Practice
Journal of Pharmaceutical Policy and Practice, Vol 14, Iss 1, Pp 1-8 (2021)

Background Drug repurposing (i.e., finding novel uses for existing drugs) is essential for maximizing medicines’ therapeutic utility, but obtaining regulatory approval for new indications is costly. Policymakers have therefore created temporary ind

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af18f85fa783df07a50861539d1657b9
https://doi.org/10.1186/s40545-020-00282-8